Business The Mugglehead technology roundup: glowing health edition Here are five companies looking to improve our collective health in different ways. Joseph MortonJune 17, 2022
Industry update Tetra Bio-Pharma enters Australia via new subsidiary acquisition Canadian company set to focus clinical trials down under, announces regulatory update Rowan DunneJune 6, 2022
Business MediPharm Labs to enter US pharmaceutical market via FDA drug registration If approved, it could advance the firm's goal of becoming a dominant supplier of cannabinoid pharmaceutical ingredients Natalia Buendia CalvilloFebruary 23, 2022
Health and Safety US CDC and FDA issue warnings on delta-8 THC The agencies are trying to crack down on the alternative cannabinoid after a surge in availability and adverse events this year Natalia Buendia CalvilloSeptember 17, 2021
CBD US Senate bill would finally allow CBD in food and drinks A bipartisan group of US senators want to mandate the FDA to regulate CBD as a dietary supplement to improve the hemp industry and... Jared GnamMay 19, 2021
News FDA lifts ban on study of therapists taking MDMA After two years of dispute, MAPS is celebrating the decision Natalia Buendia CalvilloMay 14, 2021
News 67% of PTSD sufferers drop diagnosis in first MDMA Phase 3 trial Following the successful MAPS study, MDMA-assisted therapy moves closer to becoming approved by the US FDA Natalia Buendia CalvilloMay 4, 2021
Industry update US FDA unveils plan to gather ‘real-world’ data to fill CBD research gaps After two years of delaying regulations, the agency looks to improve data-gathering methods on CBD product safety Jared GnamJanuary 11, 2021
Industry update Dousing strawberries in CBD oil reduces mould, extends shelf life: study Research from the University of South Florida suggests CBD has promising potential as an antimicrobial treatment for fresh produce Jared GnamDecember 10, 2020
CBD FDA issues cannabis research guidelines as CBD industry still hangs in limbo Vermont cannabis lawyer Timothy Fair calls FDA's two-year delay on CBD regulations 'beyond absurd' Jared GnamJuly 24, 2020